Physician profile
Andrew Johnson
NPI 1952677742
$7,096.14
in general payments reported to CMS, 2019-2025
15 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $2,512 · 2021: $207 · 2022: $130 · 2023: $224 · 2024: $1,128 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,408 · Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,407.76 |
| Food and Beverage | $1,671.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $2,500.00 | 2020 | |
| Team 1, LLC | $2,131.49 | 2024-2025 | |
| Arthrex, INC. | $1,159.80 | 2024-2025 | |
| Inspire Medical Systems, INC. | $396.21 | 2021-2023 | Inspire |
| Optinose US, INC. | $218.43 | 2019-2024 | |
| Orthofix Medical, INC. | $169.62 | 2024-2025 | Stim On Track, Spinal-Stim, Cervical-Stim |
| Glaxosmithkline, LLC. | $108.91 | 2024-2025 | Nucala |
| Genzyme Corporation | $97.59 | 2019-2024 | |
| Smith+Nephew, INC. | $75.28 | 2019-2024 | Tula |
| Stryker Corporation | $65.12 | 2019-2020 | |
| Karl Storz Endoscopy-America | $60.78 | 2024 | |
| Hologic Sales and Service, LLC | $36.36 | 2023-2024 | Coolseal Generator |
| Astrazeneca Pharmaceuticals LP | $29.04 | 2025 | Tezspire |
| Resmed Corp | $27.09 | 2024 | |
| Lilly USA, LLC | $20.42 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.